Navigation Links
Pass the Orange Tomato Sauce Please

Next time you load on the sauce, onto your pizza or spaghetti, make sure it’s made from orange tomatoes, not the usual red ones//.

Scientists from Ohio State University have reported findings, which state that lycopene- the well-known antioxidant found in tomatoes, is absorbed better by the body, when it comes from tomatoes that are orange in color.

The study is published in the Journal of Agricultural and Food Chemistry.

Lycopene is said to be a potent antioxidant that fights free radicals, which are thought to cause cancer, and ageing, battles age-related eye problems and is also good for the heart. Lycopene is found in many orange and red colored fruits and vegetables.

The researchers led by Dr. Steven Schwartz, did their study using 12 adult volunteers. They were asked to refrain from eating tomatoes or any form of the fruit up to 13 days before the commencement of the experiment.

As part of the test they were divided into two groups. One was given spaghetti and sauce made from red tomatoes and the other spaghetti with sauce made from the orange tomatoes. Blood levels of lycopene were measured before and after meals and also every hour, up to 10 hours after the meals.

It was seen that lycopene absorption from the orange tomatoes was 2.5 times higher than the one from the red tomatoes. It was also seen that 5 hours after the meals, the blood lycopene levels from the orange tomatoes were around 200 times higher than from their counterpart.

Says Schwartz: “While red tomatoes contain far more lycopene than orange tomatoes, most of it is in a form that the body doesn't absorb well.

"The people in the study actually consumed less lycopene when they ate sauce made from the orange tomatoes, but they absorbed far more lycopene than they would have if it had come from red tomatoes," he noted.

Before you rush out to buy that orange colored tomato, wait a while. The tomatoes, k
'"/>




Page: 1 2

Related medicine news :

1. A Glass of Orange Juice To Keep Recurrence Of Kidney Stones At Bay
2. Eating Live Crabs Infects 8 In Orange County
3. Mandarin Oranges Reduce Liver Cancer Risk
4. An Orange a Day may Keep Heart Disease Away
5. Tomatoes for the heart
6. Tomato Sauce reduces Cancer Risk- Study
7. A Tomato a Day Keeps Heart Disease Away
8. Tomatoes Might Inhibit the Development Of Prostate Cancer
9. Tomato Extract Found To Reduce The Risk Of Thrombosis
10. Tomato: The Vaccine Plant, Against Bird Flu
11. Raspberries Are Richer In Anti-Oxidants Than Tomatoes Or Broccoli
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Pass the Orange Tomato Sauce Please

(Date:7/9/2008)... InsuranceSpecialists.com, ...otes for almost a decade, now offers comprehensive...n presidential candidates are taking on health ref...ertisement-free, supplies unbiased material on med...s to help consumers make the best choices in cover...
(Date:7/8/2008)...Cincinnati, OH, July 7, 2008Girls moving through a...ht gain, but the reasons for this are not always c...in are easily overlooked. A new study soon to be ...the effect of Internet usage, sleep, and alcohol a... girls. , Dr. Catherine Berkey and colleagues ...
(Date:7/8/2008)...ose who had phlebotomy were 37% less likely to dev...hDay News) -- Blood letting to reduce levels of ir...uce their chance of developing cancer, according t...ood have previously been linked with a lower cance...ults were based on a randomized controlled trial o...
(Date:7/8/2008)... Physicians Cite Patient Concerns about Delays in...NGTON, Va., July 8 /PRNewswire-USNewswire/ -- The ...le medical equipment has created,concern and chaos...,officials, and home medical equipment providers a...etropolitan areas on July 1., The bidding program...
Breaking Medicine News(10 mins):Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 2Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 3Health News:The Internet, alcohol and sleep 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5
...ll be cycling across the Indian state of Rajasthan... of the women and children living in the state.// ... between 16 November and 26 November 2006. Jayne W...eportedly undergoing training to accomplish this t...
... developing chronic lung problems and asthma if th...ding to Alfred Bernard, the professor of toxicolog...e also added that the levels of the irritant trich...paddling pools than in adult pools, and that his r...
...onging to the Tulane University have come to the c...ure heart problems and the hardening of the arteri...ical markers of inflammation. //A test that is rel...y the researchers for testing of inflammations. ...
...de in diagnoses and treatment of the fatal childho...result in a cure rate of 90%, according to researc... Hospital.// The progressive improvement in the ...children with ALL survived, reflects in large part...
Other Medicine News:Health News:Children Face Risk While Swimming 2Health News:Acute Lymphoblastic Leukemia May Attain a 90% Cure Rate 2
(Date:7/7/2008)...Newswire-FirstCall/ -- Biopure Corporation,(Nasdaq...ons with the Food,and Drug Administration (FDA) on...a new clinical trial of Hemopure(R) [hemoglobin gl...roposed to study use of Hemopure,in patients suffe...use,transfusion with blood components. Currently, ...
(Date:7/6/2008)...keting Authorization Application currently ..., July 7 /- Cell Therapeuti...ed the publication of results from its,randomized ...oliglumex,CT-2103) with gemcitabine or vinorelbin... patients with previously untreated non-small cell...
(Date:7/3/2008)...BRIDGE Massachusetts, July 3,/PRNewswire-FirstCall...logy company, Jerini AG for an equity purchase pr... (HAE) product, FIRAZYR(R), to its Human Genetic ...global sales expected to be around $350-400 milli...e environment, - Expected to be accretive for Non...
(Date:7/1/2008)...Regimen sNDA Targeted for Fiscal Year-end ...J., July 1, 2008 /- Eisai Corporation...efficacy data from a trial,initiated in 2002 compa...re,(BSC) in elderly patients with myelodysplastic ...atistically significant advantage of Dacogen,treat...
Breaking Medicine Technology:Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 2Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 3Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 4Mutant gene causes epilepsy intellectual disability in women 19019 1Mutant gene causes epilepsy intellectual disability in women 19019 2Key step in the puncture mechanism of cell death revealed 19016 1Key step in the puncture mechanism of cell death revealed 19016 2PLC Medical Systems to Demonstrate RenalGuard 28TM 29 at EuroPCR 2008 19013 1PLC Medical Systems to Demonstrate RenalGuard 28TM 29 at EuroPCR 2008 19013 2PLC Medical Systems to Demonstrate RenalGuard 28TM 29 at EuroPCR 2008 19013 3PLC Medical Systems to Demonstrate RenalGuard 28TM 29 at EuroPCR 2008 19013 4Diet Industry Newcomer Hits the 1 Million Unit Mark 19010 1Diet Industry Newcomer Hits the 1 Million Unit Mark 19010 2
...sented at Society for Biomolecular Sciences Confer...wire-FirstCall/ --,Lexicon Genetics Incorporated a...g potential therapeutic targets related to its,col... Biomolecular,Sciences 13th Annual Conference &...coveries were made in a collaboration,between Lexi...
... RIDGE, N.J., April 19, 2007 /PRNewswire-FirstCall...-based,biopharmaceutical company focused on acquir...r compounds, announced data from its,preclinical s...vation for the treatment of solid and hematologic ...r at the April 2007,Annual Meeting of the American...
Other Medicine Technology:Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 2Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 3Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 4Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 5VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5
Facilitates retrieval of polypropylene guide thread from the nasal cavity when using Ritleng Bicanalicular systems and self threading Monoka systems.
...ead-guide reducing time and trauma in lacrimal duc... into the nasolacrimal duct and a thin prolene thr...hdrawn leaving the polypropylene thread to pull th... or Imperforate Nasolacrimal Duct. Silicone, Blue ...
...ead-guide reducing time and trauma in lacrimal duc... into the nasolacrimal duct and a thin prolene thr...hdrawn leaving the polypropylene thread to pull th... or Imperforate Nasolacrimal Duct. Silicone, Blue ...
For canalicular laceration or imperforate nasolacrimal duct. Medical grade silicone and Stainless Steel Probe. Box of 3, sterile. Note: Tubing securely swaged into malleable stainless steel probes. S
Medicine Products: